| 1.24 0 (0%) | 09-30 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.26  |
1-year : | 1.54 |
| Resists | First : | 1.07 |
Second : | 1.32 |
| Pivot price | 0.84 |
|||
| Supports | First : | 0.68 | Second : | 0.57 |
| MAs | MA(5) : | 0.74 |
MA(20) : | 0.91 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 8.2 |
D(3) : | 5.7 |
| RSI | RSI(14): 34.7 |
|||
| 52-week | High : | 3.16 | Low : | 0.68 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MJID ] has closed above bottom band by 28.7%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 0.73 - 0.73 | 0.73 - 0.73 |
| Low: | 0.68 - 0.69 | 0.69 - 0.69 |
| Close: | 0.71 - 0.71 | 0.71 - 0.72 |
Mon, 29 Sep 2025
Majestic Ideal Holdings Reports Significant Revenue Decline in H1 2025 - TipRanks
Fri, 26 Sep 2025
Majestic Ideal Holdings Ltd Rebrands to Ping An Biomedical Co., Ltd. - TipRanks
Fri, 26 Sep 2025
Growth or Bubble? Decoding MJID Stock’s Rapid Rise - StocksToTrade
Fri, 12 Sep 2025
Majestic Ideal Holdings to rebrand as Ping An Biomedical - Investing.com
Fri, 12 Sep 2025
Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting - 富途牛牛
Fri, 12 Sep 2025
Hong Kong Biotech Firm Majestic Ideal Transforms to Ping An Biomedical in Strategic Rebrand - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 21 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 66.4 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 702 (K) |
| Shares Short P.Month | 279 (K) |
| EPS | -0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.41 |
| Profit Margin | -1.5 % |
| Operating Margin | -2.7 % |
| Return on Assets (ttm) | -0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -17.2 % |
| Gross Profit (p.s.) | 0.26 |
| Sales Per Share | 4.27 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 15 (M) |
| Levered Free Cash Flow | 33 (M) |
| PE Ratio | -75 |
| PEG Ratio | 0 |
| Price to Book value | -1.88 |
| Price to Sales | 0.17 |
| Price to Cash Flow | 1.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|